BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17665436)

  • 1. The HLA-B*2709 subtype in a woman with early ankylosing spondylitis.
    Olivieri I; D'Angelo S; Scarano E; Santospirito V; Padula A
    Arthritis Rheum; 2007 Aug; 56(8):2805-7. PubMed ID: 17665436
    [No Abstract]   [Full Text] [Related]  

  • 2. Adalimumab reduces spinal symptoms in active ankylosing spondylitis: clinical and magnetic resonance imaging results of a fifty-two-week open-label trial.
    Haibel H; Rudwaleit M; Brandt HC; Grozdanovic Z; Listing J; Kupper H; Braun J; Sieper J
    Arthritis Rheum; 2006 Feb; 54(2):678-81. PubMed ID: 16447247
    [No Abstract]   [Full Text] [Related]  

  • 3. Spondyloarthritis research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis.
    Maksymowych WP; Inman RD; Salonen D; Dhillon SS; Williams M; Stone M; Conner-Spady B; Palsat J; Lambert RG
    Arthritis Rheum; 2005 Oct; 53(5):703-9. PubMed ID: 16208659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraarticular injection of infliximab.
    Sakellariou GT; Kakavouli G; Chatzigiannis I
    J Rheumatol; 2006 Sep; 33(9):1912-3; author reply 1913. PubMed ID: 16960955
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of low-dose infliximab on spinal inflammation on magnetic resonance imaging in ankylosing spondylitis.
    Rudwaleit M
    J Rheumatol; 2010 Aug; 37(8):1553-5. PubMed ID: 20675850
    [No Abstract]   [Full Text] [Related]  

  • 6. A Sardinian patient with ankylosing spondylitis and HLA-B*2709 co-occurring with HLA-B*1403.
    Cauli A; Vacca A; Mameli A; Passiu G; Fiorillo MT; Sorrentino R; Mathieu A
    Arthritis Rheum; 2007 Aug; 56(8):2807-9. PubMed ID: 17665402
    [No Abstract]   [Full Text] [Related]  

  • 7. Marked reduction of sacroiliac joint inflammation on magnetic resonance imaging in a patient with ankylosing spondylitis after rituximab treatment.
    Huang Y; Cheng F; Zhang X; Tang J
    J Rheumatol; 2011 Sep; 38(9):2083-4. PubMed ID: 21885528
    [No Abstract]   [Full Text] [Related]  

  • 8. MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis.
    Rudwaleit M; Schwarzlose S; Hilgert ES; Listing J; Braun J; Sieper J
    Ann Rheum Dis; 2008 Sep; 67(9):1276-81. PubMed ID: 18006539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting outcome in ankylosing spondylitis.
    Pradeep DJ; Keat A; Gaffney K
    Rheumatology (Oxford); 2008 Jul; 47(7):942-5. PubMed ID: 18492709
    [No Abstract]   [Full Text] [Related]  

  • 10. Magnetic resonance imaging in ankylosing spondylitis.
    Zochling J; Baraliakos X; Hermann KG; Braun J
    Curr Opin Rheumatol; 2007 Jul; 19(4):346-52. PubMed ID: 17551364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body magnetic resonance imaging evaluation of widespread inflammatory lesions in a patient with ankylosing spondylitis before and after 1 year of treatment with infliximab.
    Appel H; Hermann KG; Althoff CE; Rudwaleit M; Sieper J
    J Rheumatol; 2007 Dec; 34(12):2497-8. PubMed ID: 18061968
    [No Abstract]   [Full Text] [Related]  

  • 12. When less is more.
    Deodhar A
    J Rheumatol; 2010 Jun; 37(6):1089-90. PubMed ID: 20516035
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study on the association of ankylosing spondylitis with HLA-B and HLA-DRB1].
    Cai Q; Han XH; Chen LW; Yang B; Lu JQ
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):992-4. PubMed ID: 16061008
    [No Abstract]   [Full Text] [Related]  

  • 14. Vertebral sarcoid mimicking ankylosing spondylitis or just a co-incidence?
    Malaviya AN; Sawhney S; Kapoor S; Garg S
    J Assoc Physicians India; 2010 Nov; 58():709-11. PubMed ID: 21510471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ankylosing spondylitis.
    Braun J; Sieper J
    Lancet; 2007 Apr; 369(9570):1379-1390. PubMed ID: 17448825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to define remission in ankylosing spondylitis?
    Sieper J
    Ann Rheum Dis; 2012 Apr; 71 Suppl 2():i93-5. PubMed ID: 22460148
    [No Abstract]   [Full Text] [Related]  

  • 17. Defining the Minimally Important Change for the SpondyloArthritis Research Consortium of Canada Spine and Sacroiliac Joint Magnetic Resonance Imaging Indices for Ankylosing Spondylitis.
    Maksymowych WP; Lambert RG; Brown LS; Pangan AL
    J Rheumatol; 2012 Aug; 39(8):1666-74. PubMed ID: 22753648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period.
    Braun J; Deodhar A; Dijkmans B; Geusens P; Sieper J; Williamson P; Xu W; Visvanathan S; Baker D; Goldstein N; van der Heijde D;
    Arthritis Rheum; 2008 Sep; 59(9):1270-8. PubMed ID: 18759257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ankylosing spondylitis in female systemic lupus erythematosus: a rare combination.
    Mrabet D; Rekik S; Sahli H; Trojet S; Cheour I; Eleuch M; Osmane AB; Meddeb N; Sellami S
    Lupus; 2011 Jun; 20(7):777-8. PubMed ID: 21372200
    [No Abstract]   [Full Text] [Related]  

  • 20. Mixed response to tocilizumab for ankylosing spondylitis.
    Henes JC; Horger M; Guenaydin I; Kanz L; Koetter I
    Ann Rheum Dis; 2010 Dec; 69(12):2217-8. PubMed ID: 20525837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.